Yossi Maimon

2009 - Protalix BioTherapeutics

In 2009, Yossi Maimon earned a total compensation of $640.6K as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 15% increase compared to previous year.

Compensation breakdown

Bonus$160,000
Option Awards$253,030
Salary$186,478
Other$41,051
Total$640,559

Maimon received $253K in option awards, accounting for 40% of the total pay in 2009.

Maimon also received $160K in bonus, $186.5K in salary and $41.1K in other compensation.

Rankings

In 2009, Yossi Maimon's compensation ranked 5,981st out of 9,885 executives tracked by ExecPay. In other words, Maimon earned more than 39.5% of executives.

ClassificationRankingPercentile
All
5,981
out of 9,885
40th
Division
Manufacturing
2,163
out of 3,690
41st
Major group
Chemicals And Allied Products
466
out of 871
47th
Industry group
Drugs
310
out of 643
52nd
Industry
Biological Products, Except Diagnostic Substances
59
out of 138
57th
Source: SEC filing on May 21, 2012.

Maimon's colleagues

We found three more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2009.

2009

David Aviezer

Protalix BioTherapeutics

Chief Executive Officer

2009

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

2009

Yoseph Shaaltiel

Protalix BioTherapeutics

Executive Vice President, Research and Development

News

You may also like